Equities

TYK Medicines Inc

TYK Medicines Inc

Actions
  • Price (HKD)23.95
  • Today's Change-0.55 / -2.24%
  • Shares traded53.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 202320232022
OPERATIONS
Net income(383)(312)
Depreciation/depletion2211
Non-Cash items10477
Cash taxes paid, supplemental----
Cash interest paid, supplemental00
Changes in working capital51(1.66)
Total cash from operations(201)(220)
INVESTING
Capital expenditures(77)(88)
Other investing and cash flow items, total150(70)
Total cash from investing73(158)
FINANCING
Financing cash flow items5528
Total cash dividends paid----
Issuance (retirement) of stock, net185325
Issuance (retirement) of debt, net(16)(1.61)
Total cash from financing224351
NET CHANGE IN CASH
Foreign exchange effects0.010
Net change in cash96(27)
Net cash-begin balance/reserved for future use91118
Net cash-end balance/reserved for future use18791
SUPPLEMENTAL INCOME
Depreciation, supplemental2211
Cash interest paid, supplemental00
Cash taxes paid, supplemental----
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.